197 related articles for article (PubMed ID: 17451951)
21. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.
Baba Y; Hirukawa N; Sodeoka M
Bioorg Med Chem; 2005 Sep; 13(17):5164-70. PubMed ID: 15951185
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of norcantharidin derivatives as protein phosphatase-1 inhibitors.
Zhao J; Guan XW; Chen SW; Hui L
Bioorg Med Chem Lett; 2015 Jan; 25(2):363-6. PubMed ID: 25466711
[TBL] [Abstract][Full Text] [Related]
23. Cantharidin-based small molecules as potential therapeutic agents.
Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
[TBL] [Abstract][Full Text] [Related]
24. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin.
Shou LM; Zhang QY; Li W; Xie X; Chen K; Lian L; Li ZY; Gong FR; Dai KS; Mao YX; Tao M
Oncol Rep; 2013 Sep; 30(3):1059-66. PubMed ID: 23835679
[TBL] [Abstract][Full Text] [Related]
25. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin).
Baba Y; Hirukawa N; Tanohira N; Sodeoka M
J Am Chem Soc; 2003 Aug; 125(32):9740-9. PubMed ID: 12904040
[TBL] [Abstract][Full Text] [Related]
26. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
Peng F; Wei YQ; Tian L; Yang L; Zhao X; Lu Y; Mao YQ; Kan B; Lei S; Wang GS; Jiang Y; Wang QR; Luo F; Zou LQ; Liu JY
J Cancer Res Clin Oncol; 2002 Apr; 128(4):223-30. PubMed ID: 11935314
[TBL] [Abstract][Full Text] [Related]
28. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.
Li YM; Mackintosh C; Casida JE
Biochem Pharmacol; 1993 Oct; 46(8):1435-43. PubMed ID: 8240393
[TBL] [Abstract][Full Text] [Related]
29. Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?
McCuskey A; Keane MA; Mudgee LM; Sim AT; Sakoff J; Quinn RJ
Eur J Med Chem; 2000 Oct; 35(10):957-64. PubMed ID: 11121622
[TBL] [Abstract][Full Text] [Related]
30. Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
Chattopadhyay D; Swingle MR; Salter EA; Wood E; D'Arcy B; Zivanov C; Abney K; Musiyenko A; Rusin SF; Kettenbach A; Yet L; Schroeder CE; Golden JE; Dunham WH; Gingras AC; Banerjee S; Forbes D; Wierzbicki A; Honkanen RE
Biochem Pharmacol; 2016 Jun; 109():14-26. PubMed ID: 27002182
[TBL] [Abstract][Full Text] [Related]
31. The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation.
Knapp J; Bokník P; Linck B; Lüss H; Müller FU; Nacke P; Neumann J; Vahlensieck U; Schmitz W
Br J Pharmacol; 1997 Feb; 120(3):421-8. PubMed ID: 9031745
[TBL] [Abstract][Full Text] [Related]
32. Conjugates of podophyllotoxin and norcantharidin as dual inhibitors of topoisomeraseⅡ and protein phosphatase 2A.
Tang ZB; Chen YZ; Zhao J; Guan XW; Bo YX; Chen SW; Hui L
Eur J Med Chem; 2016 Nov; 123():568-576. PubMed ID: 27517805
[TBL] [Abstract][Full Text] [Related]
33. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
34. Overview of Cantharidin and its Analogues.
Wang G; Dong J; Deng L
Curr Med Chem; 2018; 25(17):2034-2044. PubMed ID: 28413963
[TBL] [Abstract][Full Text] [Related]
35. Norcantharidin-induced post-G(2)/M apoptosis is dependent on wild-type p53 gene.
Hong CY; Huang SC; Lin SK; Lee JJ; Chueh LL; Lee CH; Lin JH; Hsiao M
Biochem Biophys Res Commun; 2000 Sep; 276(1):278-85. PubMed ID: 11006118
[TBL] [Abstract][Full Text] [Related]
36. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.
Honkanen RE
FEBS Lett; 1993 Sep; 330(3):283-6. PubMed ID: 8397101
[TBL] [Abstract][Full Text] [Related]
37. Effect of norcantharidin on N-acetyltransferase activity in HepG2 cells.
Wu LT; Chung JG; Chen JC; Tsauer W
Am J Chin Med; 2001; 29(1):161-72. PubMed ID: 11321474
[TBL] [Abstract][Full Text] [Related]
38. The effects of cantharidin and cantharidin derivates on tumour cells.
Liu D; Chen Z
Anticancer Agents Med Chem; 2009 May; 9(4):392-6. PubMed ID: 19442040
[TBL] [Abstract][Full Text] [Related]
39. Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery.
Deng L; Dong J; Wang W
Mini Rev Med Chem; 2013 Jun; 13(8):1166-76. PubMed ID: 23373656
[TBL] [Abstract][Full Text] [Related]
40. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.
Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE
Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]